Regulators say, however, the benefits of vaccination with Abrysvo and Arexvy in preventing respiratory syncytial virus ...

The FDA has required the manufacturers of the RSV Vaccines Abrysvo and Arexvy to add a new warning to their labels about the ...

Read about vaccine sales, Akums and more in the latest Market Talks covering Health Care.

The CDC recommends a single dose of any FDA-approved RSV vaccine for all adults ages 75 years and older, as well as for 60- ...

As for GBS itself, this neurological ailment can be severe, attacking nerves and warranting hospitalisation for weeks or ...

On Tuesday, January 7, the FDA announced it would now be requiring GSK and Pfizer’s RSV vaccines to hold warnings of a risk ...

The FDA will require GSK and Pfizer to include on the label of their respiratory syncytial virus (RSV) vaccines a warning ...

据外媒新闻，美国FDA要求辉瑞和葛兰素史克（GSK）生产的呼吸道合胞病毒（RSV）疫苗须在标签上增加有关罹患吉兰-巴雷综合征（GBS）风险的警告。吉兰-巴雷综合征是一种罕见的神经系统疾病，其病因可能与感染和免疫反应有关，特征性症状为对称性的肢体无力、 ...

The US Food and Drug Administration has imposed a label change for two new respiratory syncytial virus (RSV) vaccine rivals.

Barré syndrome, although it said data don’t prove a causal link and affirmed the shots’ benefit outweighs their risks.

A post-marketing review by the FDA detected an increased risk of the autoimmune condition in patients inoculated with GSK’s ...

FDA updates safety labels for Pfizer's Abrysvo and GSK's Arexvy RSV vaccines, citing increased Guillain-Barré syndrome risk.